Latest Tissue plasminogen activator Stories
Patents granted for innovative minimally invasive technology for Acute Ischemic Stroke treatment, strengthening Neuravi's patent portfolio. Galway, Ireland
Experienced in European and Global Medical Technology Launches NEW YORK, Sept 23, 2014 /PRNewswire/ -- Vesselon, Inc.
Enrollment in Worldwide Trial Continues as Planned REDMOND, Wash., Sept.
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness.
Placement Agent Spencer Trask Ventures Rallies investors to "Take Stock in Stroke" NEW YORK, Aug. 4, 2014 /PRNewswire/ -- Vesselon, Inc.
HOUSTON, June 4, 2014 /PRNewswire-USNewswire/ -- The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center
REHOVOT, Israel, June 2, 2014 /PRNewswire/ -- D-Pharm Ltd.
UVA's stroke program has received the highest quality award from the American Heart Association. Charlottesville,VA (PRWEB) April 24, 2014 The American
Administering a clot-dissolving drug to stroke victims quickly — ideally within the first 60 minutes after they arrive at a hospital emergency room — is crucial to saving their lives, preserving their brain function and reducing disability.
Using an ambulance that included a computed tomography (CT) scanner, point-of-care laboratory, telemedicine connection and a specialized prehospital stroke team resulted in decreased time to treatment for ischemic stroke.
- Large; stout; burly.